Assessing the cause of tinnitus for therapeutic options

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 10, 2008, Pages 1183-1196

  Herraiz, C ^a,b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

Author keywords

Auditory discrimination training; Pulsatile tinnitus; Somatic tinnitus; Tinnitus; Tinnitus retraining therapy; Transcranial magnetic stimulation; Transtympanic

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACAMPROSATE; ACETAZOLAMIDE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE; BETAHISTINE; CARBAMAZEPINE; CORTICOSTEROID; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; FLUNARIZINE; FUROSEMIDE; GABAPENTIN; GENTAMICIN; LIDOCAINE; MEMANTINE; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERAMEXANE; NIMODIPINE; PENTOXIFYLLINE; PLACEBO; PREGABALIN; STEROID; SULPIRIDE; UNINDEXED DRUG; VASOACTIVE AGENT;

ACUTE OTITIS MEDIA; ANXIETY; AUDITORY CORTEX; AUDITORY DISCRIMINATION; AUDITORY STIMULATION; AUDITORY THRESHOLD; BRAIN ATHEROSCLEROSIS; BRAIN MAPPING; CLINICAL TRIAL; COGNITIVE THERAPY; DEAFFERENTATION; DEPRESSION; DIAGNOSTIC ACCURACY; GINKGO BILOBA; GLOMUS TUMOR; HEARING AID; HUMAN; HYPERBARIC OXYGEN; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MENIERE DISEASE; MIDDLE EAR TUMOR; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROLOGIC EXAMINATION; NEUROMODULATION; NOISE INJURY; NONHUMAN; OTOACOUSTIC EMISSION; OTOSCLEROSIS; PATIENT COUNSELING; REVIEW; SODIUM RESTRICTION; SOMATOSENSORY SYSTEM; STAPEDECTOMY; STRESS MANAGEMENT; SURGICAL DRAINAGE; TINNITUS; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; UNSPECIFIED SIDE EFFECT; VERTIGO;

EID: 69749089358     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.10.1183     Document Type: Review

References (77)

1. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990;8:221-54
2. Hoffman HJ, Reed GW. Epidemiology of tinnitus. In: Snow JB, editor, Tinnitus: theory and management. BC Decker, Inc., Hamilton-London; 2004. p. 16-41
3. Weisz N, Muller S, Schlee W, et al. The neural code of auditory phantom perception. J Neurosci 2007;27:1479-84
4. Noreña AJ, Gourévitch B, Aizaqa N, et al. Enriched acoustic environment disrupts frequency representation in cat auditory cortex. Nat Neurosci 2006;9:932-9
5. Møller A. The role of neural plasticity in tinnitus. Prog Brain Res 2007;166:37-45
6. Eggermont JJ. Pathophysiology of tinnitus. Prog Brain Res 2007;166:19-35
7. Weisz N, Dohrmann K et Elbert T. The relevance of spontaneous activity for the coding of the tinnitus sensation. Prog Brain Res 2007;166:61-70
8. Eggermont JJ, Roberts LE. The neuroscience of rinnitus [review]. Trends Neurosci 2004;27(11):676-82
9. Mühlnickel W, Elbert T, Taub E, Flor H. Reorganization of auditory cortex in tinnitus. Proc Natl Acad Sci USA 1998;95(17):10340-3
10. Diesch E, Struve M, Rupp A, et al. Enhancement of steady-state auditory evoked magnetic fields in tinnitus. Eur J Neurosci 2004;19:1093-104
11. Weisz N, Moratti S, Meinzer M, et al Tinnitus perception and distress is related to abnormal spontaneous brain activity as measured by magnetoencephalography. PLoS Med 2005;2.e153
12. Shulman A. Clinical types of tinnitus. In: Shulman A, editor, Tinnitus diagnosis/treatment. San Diego. Singular; 1997. p. 329-41
13. Herraiz C, Aparicio JM. Diagnostic clues in pulsatile tinnitus (somatosounds). Acta Otorrinolaringol Esp 2007;58:426-33
14. Sismanis A. Pulsatile tinnitus. A 15-year experience. Am J Otol 1998;19:472-7
15. Moller AR. Neural plasticity and disorders of the nervous system. Cambridge University Press, Cambridge; 2006
16. Levine R. Somatic tinnitus. In: Snow JB, editors, Tinnitus theory and management. BC Decker, Inc., Hamilton, USA, 2004. p. 108-24
17. Andersson G. A cognitive-affective theory for tinnitus: experiments and theoretical implications. In: Patuzzi RB, editor, Proceedings of the Seventh International Tinnitus Seminar; Perth, Australia. University of Westen Australia, Perth; 2002. p. 197-200
18. Knobel KA, Sanchez TG. Influence of silence and attention on tinnitus erception. Otolaryngol Head Neck Surg 2008;138:18-22
19. Moller AR. Similarities between chronic pain and tinnitus. Am J Otol 1997;18:577-85
20. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus:clinical implications. Br J Audiol 1993;27:7-17
21. Jastreboff PJ, Jastreboff MM. Tinnitus Retraining Therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients. J Am Acad Audiol 2000;11:162-77
22. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2006;26:878-81
23. Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007;137:74-9
24. James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev 2001;(1):CD001873
25. Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras A, et al. Oral Administration of prednisone to control refractory vertigo in Ménière's disease: a pilot study. Otol Neurotol 2005; 26:1022-6
26. Garduño-Anaya MA, Couthino de Toledo H, Hinojosa-González R. Dexametasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005;133:285-94
27. Estola-Partanen M. Muscular tension and tinnitus: an experimental trial of trigger point injection on tinnitus. Faculty of Medicine, University of Tampere, Tampere; 2000. p. 118
28. Eriksson M, Gustafsson S, Axelsson A. Tinnitus and trigger points: a randomized cross-over study. In: Reich GE, Vernon JA, editors, Fifth International Tinnitus Seminar; Portland OR; 1995, p. 81-3
29. Hilton M, Stuart E. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2004;(2):CD003852
30. Slattery WH, Fisher LM, Iqbal Z, et al. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005;132(1):5-10
31. Witsell DL, Hannley MT, Stinnet S, et al. Treatment of tinnitus with gabapentin: a pilot study. Otol Neurotol 2007;28(1):11-5
32. Piccirillo JF, Finnell J, Vlahiotis A, et al. Relief of idiopathic subjective tinnitus: is gabapentin effective? Arch Otolaryngol Head Neck Surg 2007;133(4):390-7
33. Bakhshaee M, Ghasemi M, Azarpazhooh M, et al. Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study. Eur Arch Otorhinolaryngol 2008;265:525-30
34. Bauer CA, BrozoskI TJ. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 2006;116:675-81
35. Lopez-Gonzalez MA, Santiago AM, Esteban-Ortega F. Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. J Otolaryngol 2007;36:213-9
36. Azevedo AA, Figueiredo RR. Treatment of tinnitus with acamprosate [review]. Prog Brain Res 2007;166:273-7
37. Lobarinas E, Yang G, Sun W, et al. Salicylate- and quinine-induced tinnitus and effects of memantine. Acta Otolaryngol Suppl 2006;556:13-9
38. Figueiredo RR, Langguth B, Mello de Oliveira P, et al. Tinnitus treatment with memantine. Otolaryngol Head Neck Surg 2008;138:492-6
39. Suckfüll M, Jastreboff P, Walter U, et al. Safety and efficacy of Neramexane in tinnitus. A randomized, double-blind, placebo-controlled, clinical trial. Proceedings of the IX International Tinnitus Semminar; 2008 June; Göteborg, Sweden, OR-13
40. Ehrenberger K. Clinical experience with caroverine in inner ear diseases. Adv Otorhinolaryngol 2002;59:156-62
41. Seidman MD. Glutamate antagonists, steroids, and antioxidants as therapeutic options for hearing loss and tinnitus and the use of an inner ear drug delivery system. Int Tinnitus J 1998;4(2):148-54
42. Sakata E, Ito Y, Itoh A. Sakata clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J 1997;3(2):117-21
43. Araújo MF, Oliveira CA, Bahmad FM Jr. Intratympanic dexamethasone injections as a treatment for severe, disabling tinnitus: does it work? Arch Otolaryngol Head Neck Surg 2005;131:113-7
44. Dodson KM, Sismanis A. Intratympanic perfusion far the treatment of tinnitus. Otolaryngol Clin North Am 200407:991-1000
45. Herraiz C, Plaza G, Toledano A. Corticoterapia intratimpánica en la enfermedad de Ménière. Proceedings of the LVII Congreso, Nacional de la SEORL, Granada; 2006
46. Van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007;127:1012-7
47. Haynes DS, O'Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15
48. Wright EF, Bifano SL. Tinnitus improvement through TMD therapy. J Am Dent Assoc 1997;128:1424-32
49. Sanchez TG, da Silva Lima A, Brandão AL, et al. Somatic modulation of tinnitus: test reliability and results after repetitive muscle contraction training. Ann Otol Rhinol Laryngol 2007;116:30-5
50. Herraiz C, Taledano A, Diges I. Trans-electrical nerve stimulation (TENS) for somatic tinnitus. Prog Brain Res 2007;166:389-94
51. Herraiz C, Diges I, Vela L, et al. Evaluation of botulinum toxin in the treatment of somatic tinnitus. Proceedings of the IX International Tinnitus Semminar; 2008 June; Göteborg, Sweden, PO-82
52. Stidham KR, Solomon PH, Roberson JB. Evaluation of botulinum, toxin A in treatment of tinnitus. Otolaryngol Head Neck Surg 2005;132:883-9
53. Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. Am J Otol 1996;17:236-40
54. Herraiz C, Hernandez FJ, Plaza G, et al. Long-term clinical trial of tinnitus retraining therapy. Otolaryngol Head Neck Surg 2005;133:774-9
55. Henry JA, Loovis C, Montero M, et al. Randomized clinical trial: group counseling based on tinnitus retraining therapy. J Rehabil Res Dev 2007;44(1):21-32
56. Schaette R, Kempter R. Development of tinnitus-related neuronal hyperactivity through homeostatic plasticity after hearing loss: a computational model. Eur J Neurosci 2006;23:3124-38
57. Davis PB, Wilde RA, Steed LG, et al. Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J 2008;87:330-9
58. Lipman RI, Lipman SP. Phase-shift treatment for predominant tone tinnitus. Otolaryngol Head Neck Surg 2007;136:763-8
59. Henry JA, Schechter MA, Zaugg TL, et al. Clinical trial to compare tinnitus masking and tinnitus retraining therapy. Acta Otolaryngol Suppl 2006;(556):64-9
60. Roberts LE, Moffat G, Bosnyak DJ. Residual inhibition functions in relation to tinnitus spectra and auditory threshold shift. Acta Otolaryngol Suppl 2006;(556):27-33
61. Struve M, Diesch E, Flor H. Extinction training for tinnitus. Prog Brain Res 2007;166:461-6
62. Flor H, Hoffmann D, Struve M, Diesch E. Auditory discrimination training for the treatment of tinnitus. Appl Psychophysiol Biofeedback 2004;29(2):113-20
63. Herraiz C, Diges I, Cobo P. Auditory discrimination therapy (ADT) for tinnitus management. Prog Brain Res 2007;166:467-71
64. Herraiz C, Diges I, Cobo P, et al. Cortical reorganisation and tinnitus: principles of auditory discrimination training for tinnitus management. Eur Arch Otorhinolaryngol Doi:10.1007/s00405-008-0757-y [Accepted 2008 June]
65. Searchfield GD, Morrison-Low J, Wise K. Object identification and attention training for treating tinnitus. Prog Brain Res 2007;166:441-60
66. Robinson SK, Viirre ES, Stein MB. Antidepressant therapy in tinnitus. Hear Res 2007;226:221-31
67. Zöger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering - a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2006;26:32-9
68. Robinson SK, Viirre ES, Bailey KA, et al. Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 2005;67:981-8
69. Martinez Devesa P, Waddell A. et al. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev 2007;(1):CD005233
70. Henry JL, Wilson PH. The Psychological management of chronic tinnitus: a cognitive-behavioural approach. Allyn & Bacon Publishers, Boston MA, 2001
71. Langguth B, Hajak G, Kleinjung T, et al. Repetitive transcranial magnetic stimulation and chronic tinnitus. Acta Otolaryngol 2006;126:102-5
72. De Ridder D, Verstraeten E, Van de Kelen K, et al. Transcranial magnetic stimulation for. tinnitus: influence of tinnitus duration on stimulation parameter choice and maximal tinnitus suppression. Otol Neurotol 2005;26:616-9
73. Kleinjung T, Steffens T, Londero A, Langguth B. Transcranial magnetic stimulation (TMS) for treatment of chronic tinnitus: clinical effects. Prog Brain Res 2007;166:359-67
74. Kleinjung T, Eichhammer P, Landgrebe M, et al. Combined temporal and prefrontal transcranial magnetic stimulation for tinnitus treatment: a pilot study. Otolaryngol Head Neck Surg 2008;138:497-501
75. De Ridder D, Menovsky T, van de Heyning P. Auditory cortex stimulation for tinnitus suppression. Otol Neurotol 2008;29:574-5
76. Langguth B, Goodey R, Azevedo A, et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, 2006 July. Prog Brain Res 2007;166:525-36
77. Henry J, Meikle M, Griest S, et al. The development of a new tinnitus questionnaire: the tinnitus functional index. Proceedings of the IX International Tinnitus Semminar; 2008 June; Göteborg, Sweden, IS-24